Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis: DOACs – are we still far from using them?


Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis: DOACs – are we still far from using them?

Prof. Dr. med. Andrea De Gottardi, Universitätsklinik Insel Spital Bern, Schweiz

Prof. Dr. med. Andrea De Gottardi, Leitender Arzt am SwissLiver Center und Professor an der Universität Bern, Schweiz spricht während des
3. Hepatologie Symposiums 2018 über das Thema:
Anticoagulation treatment for portal vein thrombosis in patients with cirrhosis.